MELATONIN: A PROMISING SOLUTION TO REDUCE MUSCLE INFLAMMATION IN DIABETIC MYOPATHY

Diabetic myopathy is characterized by muscle abnormalities such as weakness, atrophy, cramps, and stiffness. It is linked to hyperglycemia, mitochondrial dysfunction, increased levels of advanced glycation end products (AGEs), fatty acid dysfunction, and inflammation. In this study, we hypothesized that melatonin, a low-cost hormone, could be an alternative for managing muscle inflammation disorders in diabetic rats.